As previously “undruggable” targets are finally being reached, the field of targeted protein degradation is truly changing the face of small molecule drug discovery. In the pursuit to demonstrate safe and effective clinical results, it's clear that a set of unique development challenges must be overcome for these novel therapeutics to achieve their seemingly limitless potential.

With 470+ attendees, 60+ speakers, 50+ new case studies, 9 pre-conference workshops & 3 dedicated streams of content, the 3^rd TPD Summit was the most comprehensive and definitive guide for large pharma, innovative biotech and leading academic researchers to capitalize on this emerging therapeutic class and make targeted protein degradation a blockbuster therapeutic approach that improves patient outcomes.

The 4th Targeted Protein Degradation Summit, taking place in October 2021, promises to be even bigger and better - register your interest here to be first to hear all about it.